Healthcare-Associated Infection Rates in Türkiye (2014-2023): A Systematic Review and Meta-Analysis
Abstract
Objective This study aimed to describe the rate of Healthcare-Associated Infections (HAIs) in hospitals in the last decade (2014-2023), Türkiye. Materials and Methods The study was conducted using the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) statements. The keywords were “Türkiye”, “healthcare-associated infections” (HAIs), “surgical site infections” (SSIs), “central line-catheter-associated bloodstream infections” (CLABSIs), “catheter-associated urinary tract infections” (CAUTI) and “ventilator-associated pneumonia” (VAP). We included all original articles reflecting the HAI rate of all adult patients in hospitals in Türkiye for at least one year of duration between January 01, 2014 and December 31, 2023. Results In total, 1171 reports, including the keywords, were retrieved, and duplications were removed. After filtering according to the title and abstract, eight original articles were selected. The quality of four reports published in peer-reviewed journals was rated as high, and the four as moderate. The rate of invasive device-associated HAIs in intensive care units (ICUs) was 4.19 (CLABSI: 1.97, CAUTI: 1.94, VAP: 6.49) and 1.88 in inpatient wards. No article was published that reflected the overall surgical site infection rate of a hospital. Conclusion We detected that in the last 10 years (2014-2023) in Türkiye, invasive device-associated HAI rates were 1.88% in inpatient wards and 4.19% in ICU. More comprehensive studies should be…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.